vs

Side-by-side financial comparison of D-Wave Quantum Inc. (QBTS) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

Sensus Healthcare, Inc. is the larger business by last-quarter revenue ($4.9M vs $2.8M, roughly 1.8× D-Wave Quantum Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -1538.0%, a 1473.9% gap on every dollar of revenue. On growth, D-Wave Quantum Inc. posted the faster year-over-year revenue change (19.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-20.0M). Over the past eight quarters, D-Wave Quantum Inc.'s revenue compounded faster (-2.7% CAGR vs -31.9%).

D-Wave Quantum Inc. is a quantum computing company with locations in Palo Alto, California and Burnaby, British Columbia. D-Wave claims to be the world's first company to sell computers that exploit quantum effects in their operation. D-Wave's early customers include Lockheed Martin, the University of Southern California, Google/NASA, and Los Alamos National Laboratory.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

QBTS vs SRTS — Head-to-Head

Bigger by revenue
SRTS
SRTS
1.8× larger
SRTS
$4.9M
$2.8M
QBTS
Growing faster (revenue YoY)
QBTS
QBTS
+81.4% gap
QBTS
19.2%
-62.2%
SRTS
Higher net margin
SRTS
SRTS
1473.9% more per $
SRTS
-64.1%
-1538.0%
QBTS
More free cash flow
SRTS
SRTS
$17.7M more FCF
SRTS
$-2.4M
$-20.0M
QBTS
Faster 2-yr revenue CAGR
QBTS
QBTS
Annualised
QBTS
-2.7%
-31.9%
SRTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
QBTS
QBTS
SRTS
SRTS
Revenue
$2.8M
$4.9M
Net Profit
$-42.3M
$-3.2M
Gross Margin
64.8%
38.4%
Operating Margin
-1266.0%
-63.8%
Net Margin
-1538.0%
-64.1%
Revenue YoY
19.2%
-62.2%
Net Profit YoY
50.8%
-304.9%
EPS (diluted)
$-0.13
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QBTS
QBTS
SRTS
SRTS
Q4 25
$2.8M
$4.9M
Q3 25
$3.7M
$6.9M
Q2 25
$3.1M
$7.3M
Q1 25
$15.0M
$8.3M
Q4 24
$2.3M
$13.1M
Q3 24
$8.8M
Q2 24
$2.2M
$9.2M
Q1 24
$2.5M
$10.7M
Net Profit
QBTS
QBTS
SRTS
SRTS
Q4 25
$-42.3M
$-3.2M
Q3 25
$-140.0M
$-943.0K
Q2 25
$-167.3M
$-1.0M
Q1 25
$-5.4M
$-2.6M
Q4 24
$-86.1M
$1.5M
Q3 24
$1.2M
Q2 24
$-17.8M
$1.6M
Q1 24
$-17.3M
$2.3M
Gross Margin
QBTS
QBTS
SRTS
SRTS
Q4 25
64.8%
38.4%
Q3 25
71.4%
39.4%
Q2 25
63.8%
39.7%
Q1 25
92.5%
52.2%
Q4 24
63.8%
54.4%
Q3 24
59.3%
Q2 24
63.6%
58.7%
Q1 24
67.3%
62.5%
Operating Margin
QBTS
QBTS
SRTS
SRTS
Q4 25
-1266.0%
-63.8%
Q3 25
-741.8%
-37.3%
Q2 25
-856.3%
-26.6%
Q1 25
-75.3%
-31.7%
Q4 24
-876.2%
13.2%
Q3 24
16.9%
Q2 24
-863.0%
21.5%
Q1 24
-710.6%
27.1%
Net Margin
QBTS
QBTS
SRTS
SRTS
Q4 25
-1538.0%
-64.1%
Q3 25
-3743.9%
-13.7%
Q2 25
-5406.4%
-14.2%
Q1 25
-36.1%
-30.8%
Q4 24
-3727.9%
11.8%
Q3 24
13.7%
Q2 24
-814.4%
17.4%
Q1 24
-702.3%
21.3%
EPS (diluted)
QBTS
QBTS
SRTS
SRTS
Q4 25
$-0.13
$-0.19
Q3 25
$-0.41
$-0.06
Q2 25
$-0.55
$-0.06
Q1 25
$-0.02
$-0.16
Q4 24
$-0.43
$0.10
Q3 24
$0.07
Q2 24
$-0.10
$0.10
Q1 24
$-0.11
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QBTS
QBTS
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$884.5M
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$852.2M
$48.1M
Total Assets
$915.8M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QBTS
QBTS
SRTS
SRTS
Q4 25
$884.5M
$22.1M
Q3 25
$836.2M
$24.5M
Q2 25
$819.3M
$22.2M
Q1 25
$304.3M
$19.1M
Q4 24
$178.0M
$22.1M
Q3 24
$22.6M
Q2 24
$19.0M
Q1 24
$14.7M
Stockholders' Equity
QBTS
QBTS
SRTS
SRTS
Q4 25
$852.2M
$48.1M
Q3 25
$670.6M
$51.2M
Q2 25
$694.3M
$52.1M
Q1 25
$207.4M
$53.0M
Q4 24
$62.6M
$55.8M
Q3 24
$54.1M
Q2 24
$-21.5M
$52.9M
Q1 24
$-37.0M
$51.2M
Total Assets
QBTS
QBTS
SRTS
SRTS
Q4 25
$915.8M
$53.0M
Q3 25
$865.8M
$58.3M
Q2 25
$843.6M
$58.9M
Q1 25
$325.6M
$60.2M
Q4 24
$199.9M
$62.2M
Q3 24
$59.9M
Q2 24
$61.8M
$58.2M
Q1 24
$48.6M
$57.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QBTS
QBTS
SRTS
SRTS
Operating Cash FlowLast quarter
$-18.4M
$-2.2M
Free Cash FlowOCF − Capex
$-20.0M
$-2.4M
FCF MarginFCF / Revenue
-727.9%
-47.9%
Capex IntensityCapex / Revenue
60.3%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.8M
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QBTS
QBTS
SRTS
SRTS
Q4 25
$-18.4M
$-2.2M
Q3 25
$-19.0M
$2.3M
Q2 25
$-15.3M
$3.1M
Q1 25
$-19.3M
$-2.7M
Q4 24
$2.0M
$-827.0K
Q3 24
$4.0M
Q2 24
$-14.5M
$4.2M
Q1 24
$-12.1M
$-8.2M
Free Cash Flow
QBTS
QBTS
SRTS
SRTS
Q4 25
$-20.0M
$-2.4M
Q3 25
$-20.1M
$2.3M
Q2 25
$-16.0M
$3.1M
Q1 25
$-19.7M
$-2.7M
Q4 24
$1.1M
$-1.1M
Q3 24
$3.6M
Q2 24
$-15.0M
$4.2M
Q1 24
$-12.4M
$-8.4M
FCF Margin
QBTS
QBTS
SRTS
SRTS
Q4 25
-727.9%
-47.9%
Q3 25
-536.5%
33.3%
Q2 25
-518.1%
42.2%
Q1 25
-131.4%
-32.2%
Q4 24
46.2%
-8.6%
Q3 24
40.9%
Q2 24
-687.7%
45.8%
Q1 24
-504.0%
-79.0%
Capex Intensity
QBTS
QBTS
SRTS
SRTS
Q4 25
60.3%
3.2%
Q3 25
27.2%
0.1%
Q2 25
24.2%
0.4%
Q1 25
2.9%
0.1%
Q4 24
41.1%
2.3%
Q3 24
3.8%
Q2 24
25.0%
0.0%
Q1 24
12.4%
2.2%
Cash Conversion
QBTS
QBTS
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

QBTS
QBTS

Transferred Over Time$2.4M89%
Other$306.0K11%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons